Why Need to Watch – Joe’s Jeans Inc (NASDAQ:JOEZ) , Deckers Outdoor Corp (NYSE:DECK) , Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) , MeadWestvaco Corp. (NYSE:MWV)

Joe’s Jeans, Inc. (NASDAQ:JOEZ) reported Q2 EPS of $0.01, $0.04 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.96 million. Joe’s Jeans Inc (NASDAQ:JOEZ) stock performance was 20.39% in last session and finished the day at $1.24. Traded volume was 4.28million shares in the last session and the average volume of the … Continue reading Why Need to Watch – Joe’s Jeans Inc (NASDAQ:JOEZ) , Deckers Outdoor Corp (NYSE:DECK) , Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) , MeadWestvaco Corp. (NYSE:MWV)

Colin Pettis07/1407/14

NASDAQ Gainers: Rediff.com India Limited (ADR) (NASDAQ:REDF), Keurig Green Mountain Inc (NASDAQ:GMCR), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Rediff.com India Limited (ADR) (NASDAQ:REDF) released its 4Q and full-year financial performance that showed somehow wanting results especially in the U.S. However, investors appeared to pay little attention to the U.S. business problems but instead looked forward to better results in the near future, just as the management promised. Rediff.com India Limited (ADR) (NASDAQ:REDF) stock performance was 23.01% in last session and finished the day … Continue reading NASDAQ Gainers: Rediff.com India Limited (ADR) (NASDAQ:REDF), Keurig Green Mountain Inc (NASDAQ:GMCR), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Jason Knox06/0906/09

Gilead Sciences GILD NASDAQ:GILD

Healthcare Losers: Bristol-Myers Squibb (NYSE:BMY), LDR Holding Corp (NASDAQ:LDRH), Vanda Pharmaceuticals (NASDAQ:VNDA), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Bristol-Myers Squibb Co (NYSE:BMY) and Urban Outfitters (URBN) retreated 6.1 percent and 3.6 percent respectively, after brokers lowered their ratings on these stocks. Weaker-than-expected first-quarter results and dismal second-quarter earnings guidance led Wal-Mart Stores (WMT) to drop 2.4 per cent. Bristol-Myers Squibb Co (NYSE:BMY) stock performance was -6.12% in last session and finished the day at $48.93. Traded volume was 28.56million shares in the last … Continue reading Healthcare Losers: Bristol-Myers Squibb (NYSE:BMY), LDR Holding Corp (NASDAQ:LDRH), Vanda Pharmaceuticals (NASDAQ:VNDA), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Mark DeFrance05/1605/16

Biotech bearish stocks: Prothena Corporation (NASDAQ:PRTA), Oncomed Pharmaceuticals (NASDAQ:OMED), Enanta Pharmaceuticals (NASDAQ:ENTA), Vanda Pharmaceuticals (NASDAQ:VNDA)

Shares of Prothena Corp PLC (NASDAQ:PRTA) were the recipient of a large increase in short interest in the month of January. As of March 14th, there was short interest totaling 824,645 shares, an increase of 35.0% from the February 28th total of 610,797 shares, AnalystRatingsNetwork.com reports. Prothena Corporation PLC (NASDAQ:PRTA) stock performance was -13.98% in last session and finished the day at $29.60. Traded volume … Continue reading Biotech bearish stocks: Prothena Corporation (NASDAQ:PRTA), Oncomed Pharmaceuticals (NASDAQ:OMED), Enanta Pharmaceuticals (NASDAQ:ENTA), Vanda Pharmaceuticals (NASDAQ:VNDA)

Colin Pettis04/0704/07

FB Nasdaq FB Facebook

Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

Chimerix Inc. (NASDAQ:CMRX) shares hit a new high on Thursday with the biotechnology firm continuing to get a boost from its decision to increase a test program for a virus-fighting drug so it can try to save a cruelly ill 7-year-old boy. Chimerix Inc. (NASDAQ:CMRX) stock performance was 2.80% in last session and finished the day at $27.14. Traded volume was 477,612.00 shares in the … Continue reading Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

John Bellich03/1703/17

Biotech Stocks Touching New Highs: Relypsa Inc. (NASDAQ:RLYP), Vanda Pharmaceuticals (NASDAQ:VNDA), OHR Pharmaceutical (NASDAQ:OHRP), Xencor (NASDAQ:XNCR)

Relypsa, Inc. (NASDAQ:RLYP) is a pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Relypsa Inc. (NASDAQ:RLYP) stock performance was 2.66% in last session and finished the day at $43.62. Traded volume was 126,739.00 shares in the last session and the average volume of the stock remained 113,686.00 shares. Relypsa … Continue reading Biotech Stocks Touching New Highs: Relypsa Inc. (NASDAQ:RLYP), Vanda Pharmaceuticals (NASDAQ:VNDA), OHR Pharmaceutical (NASDAQ:OHRP), Xencor (NASDAQ:XNCR)

Mark DeFrance03/1703/17